GENFLOW BIOSCIENCES PLC (WQ5) — Financial Flexibility Index
GENFLOW BIOSCIENCES PLC (WQ5) has a Financial Flexibility Index of -1.37x as of December 2024. Free cash flow of €-1.08 Million (operating CF €-1.08 Million minus capex €0.00) represents -1% of total liabilities (€788.92K). Also explore WQ5 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GENFLOW BIOSCIENCES PLC Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for GENFLOW BIOSCIENCES PLC across 4 annual periods. See GENFLOW BIOSCIENCES PLC (WQ5) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for GENFLOW BIOSCIENCES PLC (2021–2024)
Year-by-year free cash flow to debt coverage for GENFLOW BIOSCIENCES PLC. For the full company profile including market capitalisation, see market cap of GENFLOW BIOSCIENCES PLC.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.37x | €-1.08 Million | €-1.08 Million | €788.92K | ▲ +52.7% |
| 2023 | -2.90x | €-1.66 Million | €-1.66 Million | €571.96K | ▲ +46.7% |
| 2022 | -5.44x | €-1.37 Million | €-1.37 Million | €250.99K | ▼ -61.2% |
| 2021 | -3.38x | €-747.38K | €-747.38K | €221.43K | — |